世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

血漿の世界市場に関する洞察と2028年までの予測


Global Blood Plasma Products Market Insights and Forecast to 2028

血液の主成分である血漿は、身体機能の調節に不可欠なものです。血漿は、アルブミン、凝固因子、プロテアーゼ阻害剤、免疫グロブリンなど、いくつかの有用な成分から構成されています。これらの成分が欠乏すると... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年2月18日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

血液の主成分である血漿は、身体機能の調節に不可欠なものです。血漿は、アルブミン、凝固因子、プロテアーゼ阻害剤、免疫グロブリンなど、いくつかの有用な成分から構成されています。これらの成分が欠乏すると疾病が発症するため、基礎研究、標的研究ともに研究開発が加速している。血漿は、いくつかの慢性疾患や生命を脅かす疾患と闘う可能性があるため、さまざまな治療法において効果的な治療計画の一部となっています。
市場の分析と洞察。血液製剤の世界市場
血液製剤の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間にCAGR(年平均成長率)%で推移するとされています。
この健康危機による経済変化を十分に考慮し、2021年に血漿製品世界市場の%を占めた免疫グロブリンは、2028年までに100万米ドルの価値を持ち、COVID-19後の期間に修正された%のCAGRで成長すると予測されます。病院や診療所セグメントは、この予測期間を通して%CAGRに変更されている一方で。

中国の血漿製品の市場規模は2021年に100万米ドル、北米と欧州の血漿製品はそれぞれ100万米ドル、100万米ドルとされています。北米の割合は2021年に%、中国と欧州はそれぞれ%、%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%であることが判明しました。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの血漿製品については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界の血漿製品市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みを行っています。本レポートの購入者は、世界の血漿製品市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の血漿製品市場における持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界の血漿製品市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界の血液製剤の範囲と市場規模
血液製剤市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界の血漿製品市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
免疫グロブリン
凝固因子濃縮物
その他
用途別セグメント
病院・クリニック
研究機関
学術機関

会社別
CSL株式会社
クリエイトグループ株式会社
グリフォルスSA
武田薬品工業
オクタファーマAG
ケドリオンSPA
ビオテストAG
中国生物学製品
サンキン
LFB S.A.

地域別
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market by Application
1.3.1 Global Blood Plasma Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals And Clinics
1.3.3 Research Laboratories
1.3.4 Academic Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Products Market Perspective (2017-2028)
2.2 Blood Plasma Products Growth Trends by Region
2.2.1 Blood Plasma Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Blood Plasma Products Historic Market Size by Region (2017-2022)
2.2.3 Blood Plasma Products Forecasted Market Size by Region (2023-2028)
2.3 Blood Plasma Products Market Dynamics
2.3.1 Blood Plasma Products Industry Trends
2.3.2 Blood Plasma Products Market Drivers
2.3.3 Blood Plasma Products Market Challenges
2.3.4 Blood Plasma Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Products Players by Revenue
3.1.1 Global Top Blood Plasma Products Players by Revenue (2017-2022)
3.1.2 Global Blood Plasma Products Revenue Market Share by Players (2017-2022)
3.2 Global Blood Plasma Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Products Revenue
3.4 Global Blood Plasma Products Market Concentration Ratio
3.4.1 Global Blood Plasma Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Products Revenue in 2021
3.5 Blood Plasma Products Key Players Head office and Area Served
3.6 Key Players Blood Plasma Products Product Solution and Service
3.7 Date of Enter into Blood Plasma Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Products Breakdown Data by Type
4.1 Global Blood Plasma Products Historic Market Size by Type (2017-2022)
4.2 Global Blood Plasma Products Forecasted Market Size by Type (2023-2028)
5 Blood Plasma Products Breakdown Data by Application
5.1 Global Blood Plasma Products Historic Market Size by Application (2017-2022)
5.2 Global Blood Plasma Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Blood Plasma Products Market Size (2017-2028)
6.2 North America Blood Plasma Products Market Size by Type
6.2.1 North America Blood Plasma Products Market Size by Type (2017-2022)
6.2.2 North America Blood Plasma Products Market Size by Type (2023-2028)
6.2.3 North America Blood Plasma Products Market Share by Type (2017-2028)
6.3 North America Blood Plasma Products Market Size by Application
6.3.1 North America Blood Plasma Products Market Size by Application (2017-2022)
6.3.2 North America Blood Plasma Products Market Size by Application (2023-2028)
6.3.3 North America Blood Plasma Products Market Share by Application (2017-2028)
6.4 North America Blood Plasma Products Market Size by Country
6.4.1 North America Blood Plasma Products Market Size by Country (2017-2022)
6.4.2 North America Blood Plasma Products Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Blood Plasma Products Market Size (2017-2028)
7.2 Europe Blood Plasma Products Market Size by Type
7.2.1 Europe Blood Plasma Products Market Size by Type (2017-2022)
7.2.2 Europe Blood Plasma Products Market Size by Type (2023-2028)
7.2.3 Europe Blood Plasma Products Market Share by Type (2017-2028)
7.3 Europe Blood Plasma Products Market Size by Application
7.3.1 Europe Blood Plasma Products Market Size by Application (2017-2022)
7.3.2 Europe Blood Plasma Products Market Size by Application (2023-2028)
7.3.3 Europe Blood Plasma Products Market Share by Application (2017-2028)
7.4 Europe Blood Plasma Products Market Size by Country
7.4.1 Europe Blood Plasma Products Market Size by Country (2017-2022)
7.4.2 Europe Blood Plasma Products Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Products Market Size (2017-2028)
8.2 Asia-Pacific Blood Plasma Products Market Size by Type
8.2.1 Asia-Pacific Blood Plasma Products Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Blood Plasma Products Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Blood Plasma Products Market Share by Type (2017-2028)
8.3 Asia-Pacific Blood Plasma Products Market Size by Application
8.3.1 Asia-Pacific Blood Plasma Products Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Blood Plasma Products Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Blood Plasma Products Market Share by Application (2017-2028)
8.4 Asia-Pacific Blood Plasma Products Market Size by Region
8.4.1 Asia-Pacific Blood Plasma Products Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Blood Plasma Products Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Plasma Products Market Size (2017-2028)
9.2 Latin America Blood Plasma Products Market Size by Type
9.2.1 Latin America Blood Plasma Products Market Size by Type (2017-2022)
9.2.2 Latin America Blood Plasma Products Market Size by Type (2023-2028)
9.2.3 Latin America Blood Plasma Products Market Share by Type (2017-2028)
9.3 Latin America Blood Plasma Products Market Size by Application
9.3.1 Latin America Blood Plasma Products Market Size by Application (2017-2022)
9.3.2 Latin America Blood Plasma Products Market Size by Application (2023-2028)
9.3.3 Latin America Blood Plasma Products Market Share by Application (2017-2028)
9.4 Latin America Blood Plasma Products Market Size by Country
9.4.1 Latin America Blood Plasma Products Market Size by Country (2017-2022)
9.4.2 Latin America Blood Plasma Products Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Products Market Size (2017-2028)
10.2 Middle East & Africa Blood Plasma Products Market Size by Type
10.2.1 Middle East & Africa Blood Plasma Products Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Blood Plasma Products Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Blood Plasma Products Market Share by Type (2017-2028)
10.3 Middle East & Africa Blood Plasma Products Market Size by Application
10.3.1 Middle East & Africa Blood Plasma Products Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Blood Plasma Products Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Blood Plasma Products Market Share by Application (2017-2028)
10.4 Middle East & Africa Blood Plasma Products Market Size by Country
10.4.1 Middle East & Africa Blood Plasma Products Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Blood Plasma Products Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CSL Ltd.
11.1.1 CSL Ltd. Company Details
11.1.2 CSL Ltd. Business Overview
11.1.3 CSL Ltd. Blood Plasma Products Introduction
11.1.4 CSL Ltd. Revenue in Blood Plasma Products Business (2017-2022)
11.1.5 CSL Ltd. Recent Developments
11.2 Creat Group Corporation
11.2.1 Creat Group Corporation Company Details
11.2.2 Creat Group Corporation Business Overview
11.2.3 Creat Group Corporation Blood Plasma Products Introduction
11.2.4 Creat Group Corporation Revenue in Blood Plasma Products Business (2017-2022)
11.2.5 Creat Group Corporation Recent Developments
11.3 Grifols SA
11.3.1 Grifols SA Company Details
11.3.2 Grifols SA Business Overview
11.3.3 Grifols SA Blood Plasma Products Introduction
11.3.4 Grifols SA Revenue in Blood Plasma Products Business (2017-2022)
11.3.5 Grifols SA Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Blood Plasma Products Introduction
11.4.4 Takeda Revenue in Blood Plasma Products Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Octapharma AG
11.5.1 Octapharma AG Company Details
11.5.2 Octapharma AG Business Overview
11.5.3 Octapharma AG Blood Plasma Products Introduction
11.5.4 Octapharma AG Revenue in Blood Plasma Products Business (2017-2022)
11.5.5 Octapharma AG Recent Developments
11.6 Kedrion SpA
11.6.1 Kedrion SpA Company Details
11.6.2 Kedrion SpA Business Overview
11.6.3 Kedrion SpA Blood Plasma Products Introduction
11.6.4 Kedrion SpA Revenue in Blood Plasma Products Business (2017-2022)
11.6.5 Kedrion SpA Recent Developments
11.7 Biotest AG
11.7.1 Biotest AG Company Details
11.7.2 Biotest AG Business Overview
11.7.3 Biotest AG Blood Plasma Products Introduction
11.7.4 Biotest AG Revenue in Blood Plasma Products Business (2017-2022)
11.7.5 Biotest AG Recent Developments
11.8 China Biologic Products
11.8.1 China Biologic Products Company Details
11.8.2 China Biologic Products Business Overview
11.8.3 China Biologic Products Blood Plasma Products Introduction
11.8.4 China Biologic Products Revenue in Blood Plasma Products Business (2017-2022)
11.8.5 China Biologic Products Recent Developments
11.9 Sanquin
11.9.1 Sanquin Company Details
11.9.2 Sanquin Business Overview
11.9.3 Sanquin Blood Plasma Products Introduction
11.9.4 Sanquin Revenue in Blood Plasma Products Business (2017-2022)
11.9.5 Sanquin Recent Developments
11.10 LFB S.A.
11.10.1 LFB S.A. Company Details
11.10.2 LFB S.A. Business Overview
11.10.3 LFB S.A. Blood Plasma Products Introduction
11.10.4 LFB S.A. Revenue in Blood Plasma Products Business (2017-2022)
11.10.5 LFB S.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
Market Analysis and Insights: Global Blood Plasma Products Market
The global Blood Plasma Products market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Immunoglobulins accounting for % of the Blood Plasma Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals And Clinics segment is altered to an % CAGR throughout this forecast period.

China Blood Plasma Products market size is valued at US$ million in 2021, while the North America and Europe Blood Plasma Products are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Blood Plasma Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Plasma Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Plasma Products market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Plasma Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Plasma Products market.

Global Blood Plasma Products Scope and Market Size
Blood Plasma Products market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Blood Plasma Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other
Segment by Application
Hospitals And Clinics
Research Laboratories
Academic Institutions

By Company
CSL Ltd.
Creat Group Corporation
Grifols SA
Takeda
Octapharma AG
Kedrion SpA
Biotest AG
China Biologic Products
Sanquin
LFB S.A.

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market by Application
1.3.1 Global Blood Plasma Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals And Clinics
1.3.3 Research Laboratories
1.3.4 Academic Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Products Market Perspective (2017-2028)
2.2 Blood Plasma Products Growth Trends by Region
2.2.1 Blood Plasma Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Blood Plasma Products Historic Market Size by Region (2017-2022)
2.2.3 Blood Plasma Products Forecasted Market Size by Region (2023-2028)
2.3 Blood Plasma Products Market Dynamics
2.3.1 Blood Plasma Products Industry Trends
2.3.2 Blood Plasma Products Market Drivers
2.3.3 Blood Plasma Products Market Challenges
2.3.4 Blood Plasma Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Products Players by Revenue
3.1.1 Global Top Blood Plasma Products Players by Revenue (2017-2022)
3.1.2 Global Blood Plasma Products Revenue Market Share by Players (2017-2022)
3.2 Global Blood Plasma Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Products Revenue
3.4 Global Blood Plasma Products Market Concentration Ratio
3.4.1 Global Blood Plasma Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Products Revenue in 2021
3.5 Blood Plasma Products Key Players Head office and Area Served
3.6 Key Players Blood Plasma Products Product Solution and Service
3.7 Date of Enter into Blood Plasma Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Products Breakdown Data by Type
4.1 Global Blood Plasma Products Historic Market Size by Type (2017-2022)
4.2 Global Blood Plasma Products Forecasted Market Size by Type (2023-2028)
5 Blood Plasma Products Breakdown Data by Application
5.1 Global Blood Plasma Products Historic Market Size by Application (2017-2022)
5.2 Global Blood Plasma Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Blood Plasma Products Market Size (2017-2028)
6.2 North America Blood Plasma Products Market Size by Type
6.2.1 North America Blood Plasma Products Market Size by Type (2017-2022)
6.2.2 North America Blood Plasma Products Market Size by Type (2023-2028)
6.2.3 North America Blood Plasma Products Market Share by Type (2017-2028)
6.3 North America Blood Plasma Products Market Size by Application
6.3.1 North America Blood Plasma Products Market Size by Application (2017-2022)
6.3.2 North America Blood Plasma Products Market Size by Application (2023-2028)
6.3.3 North America Blood Plasma Products Market Share by Application (2017-2028)
6.4 North America Blood Plasma Products Market Size by Country
6.4.1 North America Blood Plasma Products Market Size by Country (2017-2022)
6.4.2 North America Blood Plasma Products Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Blood Plasma Products Market Size (2017-2028)
7.2 Europe Blood Plasma Products Market Size by Type
7.2.1 Europe Blood Plasma Products Market Size by Type (2017-2022)
7.2.2 Europe Blood Plasma Products Market Size by Type (2023-2028)
7.2.3 Europe Blood Plasma Products Market Share by Type (2017-2028)
7.3 Europe Blood Plasma Products Market Size by Application
7.3.1 Europe Blood Plasma Products Market Size by Application (2017-2022)
7.3.2 Europe Blood Plasma Products Market Size by Application (2023-2028)
7.3.3 Europe Blood Plasma Products Market Share by Application (2017-2028)
7.4 Europe Blood Plasma Products Market Size by Country
7.4.1 Europe Blood Plasma Products Market Size by Country (2017-2022)
7.4.2 Europe Blood Plasma Products Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Products Market Size (2017-2028)
8.2 Asia-Pacific Blood Plasma Products Market Size by Type
8.2.1 Asia-Pacific Blood Plasma Products Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Blood Plasma Products Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Blood Plasma Products Market Share by Type (2017-2028)
8.3 Asia-Pacific Blood Plasma Products Market Size by Application
8.3.1 Asia-Pacific Blood Plasma Products Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Blood Plasma Products Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Blood Plasma Products Market Share by Application (2017-2028)
8.4 Asia-Pacific Blood Plasma Products Market Size by Region
8.4.1 Asia-Pacific Blood Plasma Products Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Blood Plasma Products Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Plasma Products Market Size (2017-2028)
9.2 Latin America Blood Plasma Products Market Size by Type
9.2.1 Latin America Blood Plasma Products Market Size by Type (2017-2022)
9.2.2 Latin America Blood Plasma Products Market Size by Type (2023-2028)
9.2.3 Latin America Blood Plasma Products Market Share by Type (2017-2028)
9.3 Latin America Blood Plasma Products Market Size by Application
9.3.1 Latin America Blood Plasma Products Market Size by Application (2017-2022)
9.3.2 Latin America Blood Plasma Products Market Size by Application (2023-2028)
9.3.3 Latin America Blood Plasma Products Market Share by Application (2017-2028)
9.4 Latin America Blood Plasma Products Market Size by Country
9.4.1 Latin America Blood Plasma Products Market Size by Country (2017-2022)
9.4.2 Latin America Blood Plasma Products Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Products Market Size (2017-2028)
10.2 Middle East & Africa Blood Plasma Products Market Size by Type
10.2.1 Middle East & Africa Blood Plasma Products Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Blood Plasma Products Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Blood Plasma Products Market Share by Type (2017-2028)
10.3 Middle East & Africa Blood Plasma Products Market Size by Application
10.3.1 Middle East & Africa Blood Plasma Products Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Blood Plasma Products Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Blood Plasma Products Market Share by Application (2017-2028)
10.4 Middle East & Africa Blood Plasma Products Market Size by Country
10.4.1 Middle East & Africa Blood Plasma Products Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Blood Plasma Products Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CSL Ltd.
11.1.1 CSL Ltd. Company Details
11.1.2 CSL Ltd. Business Overview
11.1.3 CSL Ltd. Blood Plasma Products Introduction
11.1.4 CSL Ltd. Revenue in Blood Plasma Products Business (2017-2022)
11.1.5 CSL Ltd. Recent Developments
11.2 Creat Group Corporation
11.2.1 Creat Group Corporation Company Details
11.2.2 Creat Group Corporation Business Overview
11.2.3 Creat Group Corporation Blood Plasma Products Introduction
11.2.4 Creat Group Corporation Revenue in Blood Plasma Products Business (2017-2022)
11.2.5 Creat Group Corporation Recent Developments
11.3 Grifols SA
11.3.1 Grifols SA Company Details
11.3.2 Grifols SA Business Overview
11.3.3 Grifols SA Blood Plasma Products Introduction
11.3.4 Grifols SA Revenue in Blood Plasma Products Business (2017-2022)
11.3.5 Grifols SA Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Blood Plasma Products Introduction
11.4.4 Takeda Revenue in Blood Plasma Products Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Octapharma AG
11.5.1 Octapharma AG Company Details
11.5.2 Octapharma AG Business Overview
11.5.3 Octapharma AG Blood Plasma Products Introduction
11.5.4 Octapharma AG Revenue in Blood Plasma Products Business (2017-2022)
11.5.5 Octapharma AG Recent Developments
11.6 Kedrion SpA
11.6.1 Kedrion SpA Company Details
11.6.2 Kedrion SpA Business Overview
11.6.3 Kedrion SpA Blood Plasma Products Introduction
11.6.4 Kedrion SpA Revenue in Blood Plasma Products Business (2017-2022)
11.6.5 Kedrion SpA Recent Developments
11.7 Biotest AG
11.7.1 Biotest AG Company Details
11.7.2 Biotest AG Business Overview
11.7.3 Biotest AG Blood Plasma Products Introduction
11.7.4 Biotest AG Revenue in Blood Plasma Products Business (2017-2022)
11.7.5 Biotest AG Recent Developments
11.8 China Biologic Products
11.8.1 China Biologic Products Company Details
11.8.2 China Biologic Products Business Overview
11.8.3 China Biologic Products Blood Plasma Products Introduction
11.8.4 China Biologic Products Revenue in Blood Plasma Products Business (2017-2022)
11.8.5 China Biologic Products Recent Developments
11.9 Sanquin
11.9.1 Sanquin Company Details
11.9.2 Sanquin Business Overview
11.9.3 Sanquin Blood Plasma Products Introduction
11.9.4 Sanquin Revenue in Blood Plasma Products Business (2017-2022)
11.9.5 Sanquin Recent Developments
11.10 LFB S.A.
11.10.1 LFB S.A. Company Details
11.10.2 LFB S.A. Business Overview
11.10.3 LFB S.A. Blood Plasma Products Introduction
11.10.4 LFB S.A. Revenue in Blood Plasma Products Business (2017-2022)
11.10.5 LFB S.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD(blood)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/25 10:25

158.38 円

165.32 円

201.48 円

ページTOPに戻る